: Passing null to parameter #1 ($string) of type string is deprecated in <b>/var/www/html/diabetesnews.com/wp-content/themes/dn_default/single.php</b> on line <b>22</b><br />
)
Following the terminated partnership with Sanofi, MannKind has relaunched its ultra-rapid-acting inhaled (needle free) mealtime insulin, Afrezza. Afrezza is an ultra-rapid-acting insulin for people with type 1 and 2 diabetes, peaking in only 16-21 minutes versus about 60-90 minutes for current injected rapid-acting insulins such as Humalog and Novolog .